Annual ROA
-56.90%
+2.72%+4.56%
December 31, 2023
Summary
- As of February 7, 2025, IOVA annual return on assets is -56.90%, with the most recent change of +2.72% (+4.56%) on December 31, 2023.
- During the last 3 years, IOVA annual ROA has fallen by -23.12% (-68.44%).
- IOVA annual ROA is now -121.40% below its all-time high of -25.70%, reached on December 31, 2018.
Performance
IOVA ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-45.99%
+6.12%+11.74%
September 30, 2024
Summary
- As of February 7, 2025, IOVA quarterly return on assets is -45.99%, with the most recent change of +6.12% (+11.74%) on September 30, 2024.
- Over the past year, IOVA quarterly ROA has increased by +9.18% (+16.64%).
- IOVA quarterly ROA is now -101.23% below its all-time high of 3732.89%, reached on March 31, 2013.
Performance
IOVA Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
IOVA ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.6% | +16.6% |
| 3 y3 years | -68.4% | +10.8% |
| 5 y5 years | -121.4% | +10.8% |
IOVA ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.2% | +4.6% | -7.8% | +26.8% |
| 5 y | 5-year | -68.4% | +4.6% | -35.1% | +26.9% |
| alltime | all time | -121.4% | +99.5% | -101.2% | +99.4% |
Iovance Biotherapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -45.99%(-11.7%) |
| Jun 2024 | - | -52.11%(-5.5%) |
| Mar 2024 | - | -55.17%(-0.1%) |
| Dec 2023 | -56.90%(-4.6%) | -55.25%(-1.2%) |
| Sep 2023 | - | -55.90%(-6.8%) |
| Jun 2023 | - | -60.01%(-3.6%) |
| Mar 2023 | - | -62.24%(-0.9%) |
| Dec 2022 | -59.62%(+35.4%) | -62.79%(+6.1%) |
| Sep 2022 | - | -59.18%(+14.7%) |
| Jun 2022 | - | -51.59%(+13.7%) |
| Mar 2022 | - | -45.37%(+6.4%) |
| Dec 2021 | -44.03%(+30.3%) | -42.65%(+9.6%) |
| Sep 2021 | - | -38.91%(+8.1%) |
| Jun 2021 | - | -35.99%(+5.7%) |
| Mar 2021 | - | -34.04%(-12.9%) |
| Dec 2020 | -33.78%(-41.1%) | -39.08%(-14.4%) |
| Sep 2020 | - | -45.64%(-14.2%) |
| Jun 2020 | - | -53.22%(-15.3%) |
| Mar 2020 | - | -62.87%(+30.3%) |
| Dec 2019 | -57.32%(+123.0%) | -48.25%(+28.5%) |
| Sep 2019 | - | -37.56%(+2.6%) |
| Jun 2019 | - | -36.60%(+2.3%) |
| Mar 2019 | - | -35.79%(-2.7%) |
| Dec 2018 | -25.70%(-56.6%) | -36.79%(-19.9%) |
| Sep 2018 | - | -45.91%(+0.5%) |
| Jun 2018 | - | -45.66%(-9.7%) |
| Mar 2018 | - | -50.55%(-14.5%) |
| Dec 2017 | -59.25%(+92.6%) | -59.13%(+15.4%) |
| Sep 2017 | - | -51.25%(+5.7%) |
| Jun 2017 | - | -48.49%(+27.8%) |
| Mar 2017 | - | -37.94%(+16.3%) |
| Dec 2016 | -30.77% | -32.62%(+4.2%) |
| Sep 2016 | - | -31.30%(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | -26.90%(-0.3%) |
| Mar 2016 | - | -26.99%(+8.8%) |
| Dec 2015 | -26.18%(+1.2%) | -24.80%(-0.7%) |
| Sep 2015 | - | -24.98%(-5.6%) |
| Jun 2015 | - | -26.46%(-14.0%) |
| Mar 2015 | - | -30.76%(-35.8%) |
| Dec 2014 | -25.88%(-79.7%) | -47.88%(-52.6%) |
| Sep 2014 | - | -101.02%(-43.4%) |
| Jun 2014 | - | -178.44%(-35.0%) |
| Mar 2014 | - | -274.73%(-44.1%) |
| Dec 2013 | -127.72%(-98.9%) | -491.23%(-90.3%) |
| Sep 2013 | - | -5057.62%(+413.8%) |
| Jun 2013 | - | -984.36%(-126.4%) |
| Mar 2013 | - | 3732.89%(-156.6%) |
| Dec 2012 | -11.25 K%(+148.9%) | -6598.90%(-19.3%) |
| Sep 2012 | - | -8181.47%(+318.7%) |
| Jun 2012 | - | -1954.03%(-28.1%) |
| Mar 2012 | - | -2716.70%(+42.8%) |
| Dec 2011 | -4520.43%(+4007.2%) | -1902.07%(+65.5%) |
| Sep 2011 | - | -1148.95%(-14.2%) |
| Jun 2011 | - | -1338.94%(+511.6%) |
| Mar 2011 | - | -218.94%(+17.5%) |
| Dec 2010 | -110.06%(-33.1%) | -186.36%(+7.3%) |
| Sep 2010 | - | -173.69%(+169.7%) |
| Jun 2010 | - | -64.39%(+15.7%) |
| Mar 2010 | - | -55.67%(-82.9%) |
| Dec 2009 | -164.58%(-83.9%) | -325.39%(-55.1%) |
| Sep 2009 | - | -724.18%(+121.0%) |
| Jun 2009 | - | -327.61%(+7.5%) |
| Mar 2009 | - | -304.76%(+10.1%) |
| Dec 2008 | -1019.64% | -276.85%(+65.8%) |
| Sep 2008 | - | -166.97%(+18.3%) |
| Jun 2008 | - | -141.16%(+100.9%) |
| Mar 2008 | - | -70.28% |
FAQ
- What is Iovance Biotherapeutics annual return on assets?
- What is the all time high annual ROA for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual ROA year-on-year change?
- What is Iovance Biotherapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly ROA year-on-year change?
What is Iovance Biotherapeutics annual return on assets?
The current annual ROA of IOVA is -56.90%
What is the all time high annual ROA for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual return on assets is -25.70%
What is Iovance Biotherapeutics annual ROA year-on-year change?
Over the past year, IOVA annual return on assets has changed by +2.72% (+4.56%)
What is Iovance Biotherapeutics quarterly return on assets?
The current quarterly ROA of IOVA is -45.99%
What is the all time high quarterly ROA for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly return on assets is 3732.89%
What is Iovance Biotherapeutics quarterly ROA year-on-year change?
Over the past year, IOVA quarterly return on assets has changed by +9.18% (+16.64%)